monitoring the emergence of t790m in egfr-mutated lung cancer
Published 7 years ago • 217 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:41
dr. husain on monitoring the emergence of t790m in lung cancer
-
1:00
dr. husain on the future of monitoring t790m in lung cancer
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
4:25
how to understand egfr t790m mutations | dana-farber cancer institute
-
2:15
what is t790m?
-
1:13
identification of egfr mutations impact overall prognosis in lung cancers
-
5:45
osimertinib in t790m-mutant lung cancer
-
13:06
managing t790-negative egfr-mutated nsclc
-
3:00
egfr-resistant disease in lung cancer
-
1:41
egfr mutations in patients with lung cancer
-
1:40
dr. ramalingam on the role of osimertinib in egfr t790m-positive advanced nsclc
-
0:48
current role of immunotherapy in egfr-mutant lung cancer
-
5:29
osimertinib for the t790m resistance mutation
-
3:48
mechanisms of resistance to upfront egfr-targeted therapy
-
5:13
case 2: frontline therapy in egfr-mutated lung cancer
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
0:58
dr. camidge on inhibiting initial activating egfr mutations and the t790m resistance mutation